Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-15
2010-12-07
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S168000, C514S165000, C514S474000, C514S494000, C424S641000, C424S643000, C536S055200
Reexamination Certificate
active
07846914
ABSTRACT:
A composition and method for pain relief and the treatment and prevention of endothelial dysfunction the cause of atherosclerosis, cardiovascular disease, hypertension, and stroke in mammals comprising a therapeutically effective amount of anti-inflammatory agents comprising; NSAIDs, an amino sugar and a zinc compound combined with dietary supplements that may enhance longevity.
REFERENCES:
patent: 5804594 (1998-09-01), Murad
patent: 6596708 (2003-07-01), Petrus
patent: 6930099 (2005-08-01), Petrus
patent: 834319 (1998-04-01), None
patent: 2306109 (1997-02-01), None
Porta et al. (Physiology & Behavior (1995), 58(2), pp. 223-228).(Abstract Sent).
Lopes Vaz A (Current medical research and opinion, (1982) vol. 8, No. 3, pp. 145-9, Abstract Sent).
Rawas-Qalaji et al. (The Journal of allergy and clinical immunology, (Feb. 2006) vol. 117, No. 2, pp. 398-403, Abstract Sent).
Gu X, Simons KJ, Simons FE, Epinephrine administration by sublingual tablet, Biopharmaceutics & Drug Disposition 2002;23:213-218.
Morgan G, A quantitative illustration of the public health potential of aspirin. Medical Hypothesis, 2003;60(6):900-902.
Phillips T, Leeuwenburgh C. Lifelong aspirin supplementation as a means to extending life span. Rejuvenation Research 2004;7(4):243-251.
Gluni-Berthold HK, Berthold HK, Clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 2002;143(2):356-65.
Weiss El, et al, Inhibiting interspecies coaggregation of plaque bacteria with cranberry juice. J. Am. Dent. Assn. 1998; 129(12):1719-23.
Vattem DA. et al, Cranberry synerty for dietary management of H. pylori infections, Process Biochemistry 2004.
Leontiadis GI, et al, Proton pump inhibotor for treatment of acute peptic ulcer bleeds. The Cochrane Library, 2004, Issue 4, John Wiley & Sons.
Chan FKL, et al, Clopodogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding, NEJM 2005;352(3);238-244.
Kupferwisser LI, et al, ASA reduces vegetation bacterial density. Circulation 1999;99(21);2791-7.
Feldman A, et al, Influenza virus and endothelial cells. J. Virol 2000;74(17);8018-27.
Chang N, Serhan CN, Aspirin triggers formation of anti-inflammatory mediators. Discovery Medicine 2004;4(24);470-475.
Fessesy FM, et al. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation 2003;107:410-415.
Petrus EJ, Aspirin the golden pill. 2009 pp. 103-109 Morgan Publishing, Austin, Texas.
Mas R et al. Long-term effects of policosanol on older patients with Type 2 diabetes. Asia Pac J Clin Nutr. 2004;13 (Suppl):S101.
Advanced Medical Instruments
Henry Michael C
Jiang Shaojia Anna
LandOfFree
Composition for the treatment and prevention of endothelial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for the treatment and prevention of endothelial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the treatment and prevention of endothelial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186913